시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 연구용 항체 및 시약 시장 보고서(2025년)
Research Antibodies and Reagents Global Market Report 2025
상품코드 : 1815634
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,389,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,235,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,082,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

연구용 항체 및 시약 시장 규모는 향후 몇 년 동안 급성장할 것으로 예측됩니다. 2029년에는 CAGR 10.8%로 262억 5,000만 달러에 달할 전망입니다. 예측 기간의 성장은 고령 인구 증가, 암 및 만성질환 유병률 증가, 연구개발비 증가, 헬스케어 지출 증가, 단백질체학 벤처에 대한 자금 조달 증가, 맞춤형 의료에 대한 요구 증가, 감염성 질환의 출현 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 저농도 분자의 식별을 위한 나노기술의 고려, 매출 및 수익성 향상을 위한 혁신적인 기술 제품 출시, 첨단 항체 정제 기술 사용에 집중, 다른 연구 기관 및 센터와의 인수 및 합병 고려, R&D 연구소 및 이니셔티브에 투자하는 것 등을 들 수 있습니다.

향후 5년간 10.8%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역장벽의 부과는 독일과 스위스에서 수입되는 단클론 항체 패널과 면역조직화학 시약의 비용을 상승시킴으로써 미국의 생물의학 연구를 방해하고 과학적 발견을 지연시키며 실험실 운영비용을 상승시킬 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

의료 및 건강 연구개발(R&&D)에 대한 투자 확대는 연구용 항체 및 시약 시장의 성장을 가속할 것으로 예측됩니다. 생명과학 연구에서 항체 및 시약은 엄격한 실험, 관찰, 실험실 작업, 분석, 검사를 통해 생물학적 과정과 질병의 원인을 조사하는 데 매우 중요합니다. 예를 들어, 2024년 1월 미국 통계기관인 National Center for Science and Engineering Statistics(NCSES)에 따르면 미국의 연구개발비는 2021년 7,891억 달러에 달할 것으로 예상되며, 2022년에는 8,856억 달러로 증가할 것으로 전망하고 있습니다. 증가할 것으로 예측하고 있으며, 이는 841억 달러 증가에 해당합니다. 이처럼 헬스케어 R&&D에 대한 투자 증가는 연구용 항체 및 시약에 대한 시장 수요를 증가시킬 것으로 보입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나19와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Research antibodies and reagents are essential tools used by bio scientists as fundamental detection techniques. These antibodies play a crucial role in identifying and distinguishing specific proteins present within a diseased cell at a particular stage of its life cycle.

The primary technologies employed in research antibodies and reagents include western blot, immunofluorescence, immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay (ELISA), multiplex immunosorbent assay, immunoprecipitation, and others. Western blot, also known as western blotting, is an analytical technique in molecular biology and immunogenetics used to detect specific proteins in a sample of tissue homogenate or extract. These technologies find applications in various fields such as proteomics, drug discovery and development, and genomics. Additionally, they are widely utilized across sectors including the pharmaceutical and biotechnology industry, academic and research institutes, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The research antibodies and reagents market research report is one of a series of new reports from The Business Research Company that provides research antibodies and reagents market statistics, including research antibodies and reagents industry global market size, regional shares, competitors with a research antibodies and reagents market share, detailed research antibodies and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the research antibodies and reagents industry. This research antibodies and reagents market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The research antibodies and reagents market size has grown strongly in recent years. It will grow from $16.25 billion in 2024 to $17.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increase in pharmaceutical R&D expenditure, increased geriatric population, increased healthcare expenditure, increase in government funds for research and growth in the number of healthcare facilities.

The research antibodies and reagents market size is expected to see rapid growth in the next few years. It will grow to $26.25 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to the increasing geriatric population, increasing prevalence of cancer and chronic diseases, increasing research and development spending, rise in healthcare expenditure, increasing financing for proteomics ventures, rising requirement for customized medicine and emergence of infectious diseases. Major trends in the forecast period include focusing on considering nanotechnology for identifying low-abundant molecules, launching innovative technological products to improve sales and profitability, focus on using advanced antibody purification technologies, consider acquiring and merging with other research agencies and centers and investing in R&D labs and initiatives.

The forecast of 10.8% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of trade barriers may disrupt U.S. biomedical research by increasing costs of monoclonal antibody panels and immunohistochemistry reagents imported from Germany and Switzerland, potentially slowing scientific discovery and raising laboratory operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing investment in medical and health research and development (R&D) is expected to drive the growth of the research antibodies and reagents market. In life science research, antibodies and reagents are crucial for investigating biological processes and disease causes through rigorous experimentation, observation, laboratory work, analysis, and testing. For example, in January 2024, the National Center for Science and Engineering Statistics (NCSES), a US-based statistical agency, reported that R&D in the U.S. reached $789.1 billion in 2021, with businesses projecting an increase to $885.6 billion in 2022, representing an $84.1 billion rise. Thus, the increased investment in healthcare R&D will boost the market demand for research antibodies and reagents.

The growth of the research antibodies and reagents market is further driven by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, providing more effective and precise healthcare interventions. Research antibodies and reagents play a pivotal role in shaping precision medicine approaches, facilitating targeted diagnostics and therapies based on individual patient profiles. As evidenced in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% of the therapeutic NMEs (12 out of 35) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the surge in demand for personalized medicine propels the growth of the research antibodies and reagents market.

Major companies in the research antibodies and reagents market are increasingly focused on developing innovative products like bispecific antibodies for therapeutic applications. Bispecific antibodies (bsAbs) feature two antigen-binding sites, allowing them to target two different epitopes simultaneously. A notable example is F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, which announced in January 2022 that its bispecific antibody, Vabysmo (faricimab), received FDA approval for treating wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Vabysmo is the first bispecific antibody specifically designed for use in the eye, highlighting the advancements in antibody therapeutics.

Major players in the research antibodies and reagents market are concentrating on developing reagent solutions for immunohistochemistry to gain a competitive advantage. These reagent solutions typically comprise antibodies and blocking agents in a buffered solution. For example, in March 2023, the UK-based Aptamer Group PLC introduced Optimer-Fc, designed for use in automated immunohistochemistry workflows. Optimer-Fc is an innovative solution combining an Optimer binder with the Fc domain of an antibody, serving as a viable substitute for primary detecting antibodies in various IHC applications. This approach allows seamless integration into existing workflows, replacing the primary detecting antibody without compromising the process's integrity.

In February 2022, the US-based Rockland Immunochemicals, Inc., acquired Germany-based Antibodies-Online GmbH, marking a strategic move to enhance capabilities in designing, developing, and manufacturing antibodies and assays. This acquisition leverages Antibodies-Online's e-commerce brand, supplier network, and technology stack, providing customers with improved capabilities supported by comprehensive data sets, enhancing the overall customer experience and strengthening their market strategy.

Major companies operating in the research antibodies and reagents market include Thermo Fisher Scientific Inc., Abcam plc, Cell Signaling Technology, Inc., Merck KGaA, Santa Cruz Biotechnology, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Immunochina, Takara Bio, GE Healthcare, Zhejiang Kangte Biotechnology Co., Ltd., Wuxi Tech-star Technology Co., Ltd., Shaanxi Bloom Tech Co., Ltd., PerkinElmer Inc., Lonza Group AG, GenScript Biotech Corporation, Bio-Techne Corporation

North America was the largest region in the research antibodies and reagents market in 2024. The regions covered in the research antibodies and reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the research antibodies and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The research antibodies and reagents market consists of sales of buffers, fixatives, solvents, and enzymes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Research Antibodies and Reagents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on research antibodies and reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for research antibodies and reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The research antibodies and reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Research Antibodies and Reagents Market Characteristics

3. Research Antibodies and Reagents Market Trends And Strategies

4. Research Antibodies and Reagents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Research Antibodies and Reagents Growth Analysis And Strategic Analysis Framework

6. Research Antibodies and Reagents Market Segmentation

7. Research Antibodies and Reagents Market Regional And Country Analysis

8. Asia-Pacific Research Antibodies and Reagents Market

9. China Research Antibodies and Reagents Market

10. India Research Antibodies and Reagents Market

11. Japan Research Antibodies and Reagents Market

12. Australia Research Antibodies and Reagents Market

13. Indonesia Research Antibodies and Reagents Market

14. South Korea Research Antibodies and Reagents Market

15. Western Europe Research Antibodies and Reagents Market

16. UK Research Antibodies and Reagents Market

17. Germany Research Antibodies and Reagents Market

18. France Research Antibodies and Reagents Market

19. Italy Research Antibodies and Reagents Market

20. Spain Research Antibodies and Reagents Market

21. Eastern Europe Research Antibodies and Reagents Market

22. Russia Research Antibodies and Reagents Market

23. North America Research Antibodies and Reagents Market

24. USA Research Antibodies and Reagents Market

25. Canada Research Antibodies and Reagents Market

26. South America Research Antibodies and Reagents Market

27. Brazil Research Antibodies and Reagents Market

28. Middle East Research Antibodies and Reagents Market

29. Africa Research Antibodies and Reagents Market

30. Research Antibodies and Reagents Market Competitive Landscape And Company Profiles

31. Research Antibodies and Reagents Market Other Major And Innovative Companies

32. Global Research Antibodies and Reagents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Research Antibodies and Reagents Market

34. Recent Developments In The Research Antibodies and Reagents Market

35. Research Antibodies and Reagents Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기